Back to search
Mevalonate Kinase Deficiency
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Mevalonate Kinase Deficiency trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Mevalonate Kinase Deficiency trials you may qualify forThis is a study to evaluate safety and effectiveness of Ilaris in adult and pediatric patients receiving the drug in a clinical setting for any of the following…
Mevalonate kinase deficiency (HyperIgD syndrome, HIDS) is an inborn error of immunity caused by a block in the mevalonate pathway. The subsequent lack of isopre…
The objective of this extension protocol is to collect safety data (serious and non-serious adverse events) and to provide continuous canakinumab to patients in…
Participants wanted for study of mevalonate kinase deficiency (MKD), mevalonic aciduria, or hyperimmunoglobulinemia with periodic fever syndrome (HIDS). Patien…
The primary objective of this study was to evaluate safety and tolerability of ACZ885 in this extension study. This extension study offered the opportunity for…